Literature DB >> 19454686

The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor.

Melanie Merk1, John Baugh, Swen Zierow, Lin Leng, Utpal Pal, Seung Joon Lee, Antje D Ebert, Yuka Mizue, John O Trent, Robert Mitchell, Walter Nickel, Paula B Kavathas, Jürgen Bernhagen, Richard Bucala.   

Abstract

Macrophage migration inhibitory factor (MIF) is a leaderless protein that is secreted from cells by a specialized, nonclassical export pathway. The release of MIF nevertheless is regulated and its production in response to different inflammatory, mitogenic, and hormonal stimuli plays an important role in diverse physiologic and pathologic processes. We report herein the identification of the Golgi complex-associated protein p115 as an intracellular binding partner for MIF. MIF interacts with p115 in the cytoplasm and the stimulated secretion of MIF results in the accumulation of both proteins in supernatants, which is consistent with MIF release from cells in conjunction with p115. The depletion of p115 from monocytes/macrophages decreases the release of MIF but not other cytokines following inflammatory stimulation or intracellular bacterial infection. Notably, the small molecule MIF inhibitor 4-iodo-6-phenylpyrimidine inhibits MIF secretion by targeting the interaction between MIF and p115. These data reveal p115 to be a critical intermediary component in the regulated secretion of MIF from monocytes/macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454686      PMCID: PMC3135652          DOI: 10.4049/jimmunol.0803710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells.

Authors:  André Engling; Rafael Backhaus; Carolin Stegmayer; Christoph Zehe; Claudia Seelenmeyer; Angelika Kehlenbach; Blanche Schwappach; Sabine Wegehingel; Walter Nickel
Journal:  J Cell Sci       Date:  2002-09-15       Impact factor: 5.285

2.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

3.  Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway.

Authors:  Yonca Bulut; Emmanuelle Faure; Lisa Thomas; Hisae Karahashi; Kathrin S Michelsen; Ozlem Equils; Sandra G Morrison; Richard P Morrison; Moshe Arditi
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 4.  Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells.

Authors:  Walter Nickel; Matthias Seedorf
Journal:  Annu Rev Cell Dev Biol       Date:  2008       Impact factor: 13.827

Review 5.  Fibroblast growth factor-2.

Authors:  M A Nugent; R V Iozzo
Journal:  Int J Biochem Cell Biol       Date:  2000-02       Impact factor: 5.085

6.  Purification and characterization of macrophage migration inhibitory factor as a secretory protein from rat epididymis: evidences for alternative release and transfer to spermatozoa.

Authors:  R Eickhoff; B Wilhelm; H Renneberg; G Wennemuth; M Bacher; D Linder; R Bucala; J Seitz; A Meinhardt
Journal:  Mol Med       Date:  2001-01       Impact factor: 6.354

7.  Rapid secretion of interleukin-1beta by microvesicle shedding.

Authors:  A MacKenzie; H L Wilson; E Kiss-Toth; S K Dower; R A North; A Surprenant
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

8.  The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.

Authors:  Jodi B Lubetsky; Angeles Dios; Jialian Han; Bayan Aljabari; Bela Ruzsicska; Robert Mitchell; Elias Lolis; Yousef Al-Abed
Journal:  J Biol Chem       Date:  2002-05-07       Impact factor: 5.157

Review 9.  Adenosine triphosphate-sensitive potassium (K(ATP)) channel activity is coupled with insulin resistance in obesity and type 2 diabetes mellitus.

Authors:  Taro Wasada
Journal:  Intern Med       Date:  2002-02       Impact factor: 1.271

10.  Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.

Authors:  Peter D Senter; Yousef Al-Abed; Christine N Metz; Fabio Benigni; Robert A Mitchell; J Chesney; Jianlin Han; Carlos G Gartner; Sidney D Nelson; George J Todaro; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

View more
  56 in total

1.  Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Authors:  Yoonsang Cho; Gregg V Crichlow; Jon J Vermeire; Lin Leng; Xin Du; Michael E Hodsdon; Richard Bucala; Michael Cappello; Matt Gross; Federico Gaeta; Kirk Johnson; Elias J Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

Review 2.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

3.  AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.

Authors:  Marcel F Leyton-Jaimes; Joy Kahn; Adrian Israelson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

4.  The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).

Authors:  Melanie Merk; Swen Zierow; Lin Leng; Rituparna Das; Xin Du; Wibke Schulte; Juan Fan; Hongqi Lue; Yibang Chen; Huabao Xiong; Frederic Chagnon; Jürgen Bernhagen; Elias Lolis; Gil Mor; Olivier Lesur; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-04       Impact factor: 11.205

5.  Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.

Authors:  Amanda Sparkes; Patrick De Baetselier; Lea Brys; Inês Cabrito; Yann G-J Sterckx; Steve Schoonooghe; Serge Muyldermans; Geert Raes; Richard Bucala; Peter Vanlandschoot; Jo A Van Ginderachter; Benoît Stijlemans
Journal:  FASEB J       Date:  2018-01-25       Impact factor: 5.191

6.  Loss of autophagy enhances MIF/macrophage migration inhibitory factor release by macrophages.

Authors:  Jacinta P W Lee; Andrew Foote; Huapeng Fan; Celia Peral de Castro; Tali Lang; Sarah A Jones; Nichita Gavrilescu; Kingston H G Mills; Michelle Leech; Eric F Morand; James Harris
Journal:  Autophagy       Date:  2016-05-10       Impact factor: 16.016

7.  Lentivirus-mediated silencing of USO1 inhibits cell proliferation and migration of human colon cancer cells.

Authors:  Jinke Sui; Xu Li; Junjie Xing; Fuao Cao; Hao Wang; Haifeng Gong; Wei Zhang
Journal:  Med Oncol       Date:  2015-07-17       Impact factor: 3.064

8.  Macrophage migration inhibitory factor (MIF) of the protozoan parasite Eimeria influences the components of the immune system of its host, the chicken.

Authors:  Katarzyna B Miska; Sungwon Kim; Raymond H Fetterer; Rami A Dalloul; Mark C Jenkins
Journal:  Parasitol Res       Date:  2013-02-23       Impact factor: 2.289

9.  Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors.

Authors:  Yoonsang Cho; Jon J Vermeire; Jane S Merkel; Lin Leng; Xin Du; Richard Bucala; Michael Cappello; Elias Lolis
Journal:  Chem Biol       Date:  2011-09-23

Review 10.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.